AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study - Endpoints News

AstraZeneca's clot-fighter Brilinta shows promise in diabetics with heart disease in big study  Endpoints News

“The THEMIS trial is the largest randomised trial of patients with type-2 diabetes performed to date and was designed to evaluate whether more-intense ...